Viking Global Investors LP 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:21 am Purchase | 2023-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Viking Global Investors LP | 6,599,062 9.990% | 436,700 (+7.09%) | Filing |
| 2023-02-14 1:18 pm Purchase | 2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI | Viking Global Investors LP | 6,162,362 9.990% | 177,628 (+2.97%) | Filing |
| 2022-10-07 5:29 pm Purchase | 2022-09-27 | 13G | Trevi Therapeutics, Inc. TRVI | Viking Global Investors LP | 5,984,734 9.990% | 5,984,734 (New Position) | Filing |